Formation of blood clumps inside vessels which restrict blood circulation throughout
circulatory system is known as thrombosis. This leads to origin of numerous abnormalities …

Cardiovascular diseases, like coronary heart disease or artery disorders (arteriosclerosis,
including artery solidification), heart failure (myocardial infarction), arrhythmias, congestive …

Thrombosis, a major cause of deaths in this modern era responsible for 31% of all global
deaths reported by WHO in 2017, is due to the aggregation of fibrin in blood vessels which …

Enzyme therapies are attracting significant attention as thrombolytic drugs during the current
scenario owing to their great affinity, specificity, catalytic activity, and stability. Among various …

Cardiovascular diseases are the leading causes of death through the world. A common
cause of cardiovascular diseases is an abnormal clot formation, called “thrombus”. Although …

Cardiac disorders such as acute myocardial infarction, embolism and stroke are primarily
attributed to excessive fibrin accumulation in the blood vessels, usually consequential in …

Cardiovascular diseases are a group of disorders consisting importantly of coronary heart
disease, peripheral arterial disease, cerebrovascular disease, rheumatic heart disease …

Cardiovascular diseases are one of the leading causes of death, globally. Thrombolytic and
fibrinolytic therapies are effective treatments to dissolve the blood clots, improve the blood …

Objectives This review should give an overview about the natural human plasminogen
activators and their various modified variants as well as similar substances isolated from …

Thrombolytic drugs have been used in the clinical arena to treat a wide variety of venous
and arterial thromboembolic disorders which are a main cause of death. Thrombolytic …